Gene: DENND2A
Official Full Name: DENN domain containing 2Aprovided by HGNC
Gene Summary: Enables guanyl-nucleotide exchange factor activity. Involved in retrograde transport, endosome to Golgi. Located in actin cytoskeleton. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO27797 | DENND2A Knockout cell line (HEK293) | Human | DENND2A | 1:3~1:6 | Negative | Online Inquiry |
DENND2A Gene Knockout Cell Lines are advanced biological tools specifically engineered to facilitate the study of the DENND2A gene, which plays a crucial role in cellular processes including endosomal trafficking and signal transduction. These cell lines have been meticulously designed to express a complete knockout of the DENND2A gene, providing researchers with a unique platform to examine the gene's function and the physiological implications of its absence.
The key mechanism by which DENND2A gene knockout cell lines operate involves the disruption of endogenous DENND2A expression through CRISPR-Cas9 technology or other gene-editing methods. This alteration allows scientists to investigate how the loss of DENND2A influences cellular pathways, protein interactions, and overall cell behavior, thus offering insights into diseases linked to aberrant endosomal functions, such as cancer and neurodegeneration.
The scientific significance of these cell lines extends into both research and clinical applications. In the research environment, they serve as valuable models for studying gene function, validating therapeutic targets, and exploring genetic interactions. In clinical settings, understanding the pathways that DENND2A influences could lead to the identification of new biomarkers or therapeutic strategies for diseases associated with its dysregulation.
What sets our DENND2A gene knockout cell lines apart from alternatives is their high efficiency of gene disruption and characterization, including rigorous validation through genotyping and phenotypic analysis. Additionally, they are compatible with various downstream applications, such as high-throughput screening, gene expression studies, and proteomic analyses.
This product is invaluable for researchers and clinicians alike, empowering them to uncover the complexities of the DENND2A gene’s role in health and disease. Our company, with its deep expertise in genetic modifications and commitment to providing high-quality biological products, stands behind these cell lines, ensuring researchers have robust tools at their disposal to advance their scientific inquiries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.